Capital Flow Monitor · Sponsors · CIK 2152390
Bregma Capital Life Sciences Fund, LP
224 PRESIDIO AVE, SAN FRANCISCO, CA, 94115 · 917-415-7223
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
—
Sold
$0
% sold
—
Investors
0
Min investment
$1.0M
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | D ·current | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Mark E. Karvosky — Executive Officer, San Francisco, CA
- - Bregma Capital GP, LLC — Executive Officer, San Francisco, CA
- - Bregma Capital, LP — Executive Officer, San Francisco, CA
Placement agents
- Profor Securities, Llc · 1 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.